Abstract
One of the promising host-directed chemotherapeutic interventions in tuberculosis (TB) is based on inducing autophagy as an immune effector. Here we consider the strengths and weaknesses of potential autophagy-based pharmacological intervention. Using the existing drugs that induce autophagy is an option, but it has limitations given the broad role of autophagy in most cells, tissues, and organs. Thus, it may be desirable that the agent being used to modulate autophagy is applied in a targeted manner, e.g. delivered to affected tissues, with infected macrophages being an obvious choice. This review addresses the advantages and disadvantages of delivering drugs to induce autophagy in M. tuberculosis-infected macrophages. One option, already being tested in models, is to design particles for inhalation delivery to lung macrophages. The choice of drugs, drug release kinetics and intracellular residence times, non-target cell exposure and feasibility of use by patients is discussed. We term here this (still experimental) approach, of compartment-targeting, autophagy-based, host-directed therapy as "Track-II antituberculosis chemotherapy."
Citations
Aug 22, 2017·Frontiers in Immunology·Susanta PahariJaved N Agrewala
Dec 13, 2019·Experimental & Molecular Medicine·Yi Sak KimEun-Kyeong Jo
Oct 17, 2018·Virulence·Seungwha PaikEun-Kyeong Jo
Apr 21, 2016·Pharmaceutical Research·Anuradha GuptaAmit Misra
Dec 16, 2016·Drug Development and Industrial Pharmacy·Stefano GiovagnoliMaurizio Ricci
Jul 17, 2020·Nature Communications·Ramya Sivangala ThandiRamakrishna Vankayalapati
Feb 18, 2017·Frontiers in Immunology·Robert E BrownShen-An Hwang
Oct 12, 2018·Nature Communications·Jin Kyung KimEun-Kyeong Jo
Nov 15, 2018·Frontiers in Microbiology·Cari StekGraeme Meintjes
Oct 29, 2020·Molecular Therapy. Nucleic Acids·Reena BhartiAmit Misra
Feb 26, 2021·Frontiers in Cellular and Infection Microbiology·Retsepile E MaphasaAdmire Dube
Apr 9, 2021·Frontiers in Cellular and Infection Microbiology·Prashanta SilwalEun-Kyeong Jo
Mar 7, 2017·Molecular Pharmaceutics·Anuradha GuptaAmit Misra
Jul 28, 2016·Molecular Pharmaceutics·Anuradha GuptaAmit Misra